Postopoperarive Outcomes After Colorectal Surgery in Europe (euroPOWER) (EuroPOWER)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03814681 |
|
Recruitment Status : Unknown
Verified January 2019 by Grupo Español de Rehabilitación Multimodal.
Recruitment status was: Not yet recruiting
First Posted : January 24, 2019
Last Update Posted : January 25, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Methods
30 days European Multicentre observational cohort study of postoperative complications following elective colorectal surgery within any compliance of an ERAS protocol (including patients with 0 compliance) in a participating hospital during the 30-day cohort period with a planned overnight stay.
Research sites
Hospitals across Europe with an elective colorrectal surgical service
Objective
To provide detailed data describing post-operative complications and associated mortality To provide detailed data describing adherence to ERAS protocol and its association to morbidity and length of stay.
To provide detailed information on the influence of the volume of patients undergoing surgery on each center and postoperative complications censured at 30 days after surgery.
Inclusion criteria All adult patients (aged ≥18 years) undergoing elective colorectal surgery during the 30-day study period.
Statistical analysis Number of patients: All eligible patients undergoing elective colorectal surgery during the study month in European participating hospitals.
Univariate analysis will be used to test factors (patient, surgical, and ERAS related) associated with surgical complications, length of stay (LOS) and in-hospital death. Single and multi-level logistic regression models will be constructed to identify factors independently associated with these outcomes and to adjust for differences in confounding factors. A stepwise approach will be used to enter new terms. A single final analysis is planned at the end of the study.
Summary statistics with post hoc Bonferroni corrections will be used to assess possible dose- response dependence in percentage of patients with postoperative complications and LOS.
| Condition or disease | Intervention/treatment |
|---|---|
| Perioperative Care Colorectal Surgery Postoperative Complications | Other: Colorectal Surgery |
The results of this study will allow to identify, on the one hand, the type of patients presenting postoperative complications and, on the other hand, to identify those items of the ERAS protocols that are independently associated with a reduction in postoperative complications and hospital stay, which will allow to focus the perioperative efforts in those items that actually improve the postoperative outcomes.
- Aim 1 will establish the number of patients developing predefined postoperative complications within 30 days of surgery in adult patients undergoing elective colorectal surgery with any compliance of an ERAS protocol (including patients with 0 compliance). This will allow us to determine the actual impact of these protocols.
- Aim 2 will allow us to know the type of predefined complication presented by the patients included in the ERAS protocols and in patients undergoing colorectal surgery; This will allow, on the one hand, to have a starting point for future clinical trials, and, on the other hand, to focus efforts to avoid these complications.
- Aim 3 will allow us to identify those perioperative items of ERAS protocols that are actually associated with a decrease in postoperative complications.
The proposed study will establish a real view of the number of patients presenting postoperative complications that will overcome the limitations of available retrospective studies and provide greater insight into the items of the protocols that are associated with decreased complications; on the other hand, our hypothesis is that the number of patients who develop predefined postoperative complications within 30 days of surgery decreases as there is greater compliance with the predefined ERAS protocol items
| Study Type : | Observational |
| Estimated Enrollment : | 8000 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Postoperative Outcomes Within/Without an Enhanced Recovery After Surgery Protocol in Colorectal Surgery Across Europe |
| Estimated Study Start Date : | September 15, 2019 |
| Estimated Primary Completion Date : | December 15, 2019 |
| Estimated Study Completion Date : | January 15, 2020 |
- Other: Colorectal Surgery
elective Colorectal Surgery
- Predefined mild-moderate-severe postoperative complications [ Time Frame: 30 days after surgery ]Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine were published by the EPCO definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome mesures. infectious complications, cardiovascular complications and other types of complications. Each complication will be graded as mild, moderate or severe.
- In-hospital all-cause mortality [ Time Frame: 30 days after surgery ]The number and percentage of deaths within 30 days of surgery will be reported for each surgical category
- Compliance with ERAS items [ Time Frame: 30 days after surgery ]Overall compliance will be calculated as the average of all pre- and intraoperative ERAS adapted elements, as specified in the ERAS society colon and rectal guidelines ERAS patients' guideline compliance will be categorised into quartiles
- Duration of hospital stay [ Time Frame: 30 days after surgery ]The median hospital length of stay (LOS) following the start of surgery, overall, by survival status and by complication status will be reported. Post-operative LOS is the duration in days from the date of the end of surgery to the date of discharge from hospital.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- All adult patients (aged ≥18 years) undergoing primary elective colorectal surgery and by any approach (Includes surgery with laparoscopic, assisted laparoscopic approach or open approach) in a participating hospital during the 30-day cohort period with a planned overnight stay.
Exclusion Criteria:
-
Patients submitted for emergency surgery
- Patients with complex cancer who required resection of organs other than bowel. (i.e. kidney, gastric resection, ovarian)• Patients treated with endoscopic techniques using the hybrid TaTME technique (Transanal Total Mesorectal Excision)
- Bowel transit reconstruction surgery
- Patients who refuse to participate
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03814681
| Contact: Javier Ripollés-Melchor, MD | 649337762 | ripo542@gmail.com | |
| Contact: Javi Ripollés-Melchor | 649337762 | ripo542@gmail.com |
| Spain | |
| Hospital Universitario Infanta Leonor | |
| Madrid, Spain | |
| Study Chair: | Javier Ripollés-Melchor, MD | Infanta Leonor University Hospital, Madrid, Spain | |
| Study Chair: | Rupert Pearse, Prof | Queen Mary University London, London, UK | |
| Study Chair: | José M Ramírez Rodríguez, Prof | Lozano Blesa University Hospital, Zaragoza, Spain | |
| Study Chair: | Samir Jaber, Prof | Hospitalier Universitaire de Montpellier, France | |
| Study Chair: | Karim Slim, Prof | Président de GRACE | |
| Study Chair: | César Aldecoa, Prof | Río Hortega University Hospital, Valladolid, Spain | |
| Study Chair: | Nader Francis, Prof | Yeovil District Hospital NHS Foundation Trust | |
| Study Chair: | Ane Abad-Motos, MD | Infanta Leonor University Hospital, Madrid, Spain |
Documents provided by Grupo Español de Rehabilitación Multimodal:
| Responsible Party: | Grupo Español de Rehabilitación Multimodal |
| ClinicalTrials.gov Identifier: | NCT03814681 |
| Other Study ID Numbers: |
EuroPOWER |
| First Posted: | January 24, 2019 Key Record Dates |
| Last Update Posted: | January 25, 2019 |
| Last Verified: | January 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Postoperative Complications Pathologic Processes |